-
Signature
-
/s/ Timothy C. Dec, as attorney-in-fact
-
Issuer symbol
-
SUPN
-
Transactions as of
-
27 Aug 2025
-
Transactions value $
-
-$842,888
-
Form type
-
4
-
Filing time
-
29 Aug 2025, 16:05:45 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Khattar Jack A. |
President, CEO, Director |
C/O SUPERNUS PHARMACEUTICALS INC., 9715 KEY WEST AVENUE, ROCKVILLE |
/s/ Timothy C. Dec, as attorney-in-fact |
29 Aug 2025 |
0001539937 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
SUPN |
Common Stock |
Options Exercise |
$223,191 |
+17,195 |
+1.6% |
$12.98 |
1,088,654 |
27 Aug 2025 |
Direct |
F1 |
| transaction |
SUPN |
Common Stock |
Sale |
-$479,782 |
-10,650 |
-0.98% |
$45.05 |
1,078,004 |
27 Aug 2025 |
Direct |
F2 |
| transaction |
SUPN |
Common Stock |
Options Exercise |
$503,351 |
+38,779 |
+3.6% |
$12.98 |
1,116,783 |
28 Aug 2025 |
Direct |
F1 |
| transaction |
SUPN |
Common Stock |
Sale |
-$1,089,648 |
-24,150 |
-2.16% |
$45.12 |
1,092,633 |
28 Aug 2025 |
Direct |
F3 |
| holding |
SUPN |
Common Stock |
|
|
|
|
|
1,005,600 |
27 Aug 2025 |
By the KBT Trust |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
SUPN |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-17,195 |
-13.13% |
$0 |
113,779 |
27 Aug 2025 |
Common Stock |
17,195 |
$12.98 |
Direct |
F4 |
| transaction |
SUPN |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-38,779 |
-34.08% |
$0 |
75,000 |
28 Aug 2025 |
Common Stock |
38,779 |
$12.98 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: